Page
%P
-
Article
Open AccessSafety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study
The safety, efficacy, and pharmacokinetics of copanlisib were evaluated in this phase Ib/II study in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma (NHL). The primary endpoint was saf...
-
Article
Expandable progenitors from induced pluripotent stem cells
-
Article
CD30-targeting immunoconjugates and bystander effects
-
Article
Emerging innovation towards safety in the clinical application of ESCs and iPSCs
-
Article
A recipe for targeted therapy in prostate cancer
-
Article
The microenvironment and resistance to personalized cancer therapy